Abstract: The invention includes a class of compounds that inhibit the specific proteolytic activity of the bimolecular complex 1[TF:VII/VIIa] that initiates the blood coagulation systems. Both reversible and irreversible inhibitors are disclosed.The invention encompasses the use of inhibitors of the active site of the factor VII and VIIa component of [TF:VII/VIIa] as diagnostic reagents, as analytical reagents, and as therapeutic drugs.The invention includes the compounds based on the following general formula for both reversible and irreversible selective inhibition of [TF:VII/VIIa].
Abstract: New physiologically active substances, named probestin and prostatin, respectively, are produced from a new microorganism, Streptomyces azureus MH663-2F6 strain identified as FERM P-9541 or FERM BP-1963. Probestin and prostatin have an activity inhibitory to aminopeptidase M and also have immunopotentiating properties.
Type:
Grant
Filed:
August 16, 1988
Date of Patent:
June 4, 1991
Assignee:
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
Inventors:
Tomio Takeuchi, Takaaki Aoyagi, Masa Hamada, Hiroshi Naganawa, Shigemi Yoshida
Abstract: A novel elastomeric composition of matter comprises a rubber latex and a masterbatch comprising a therapeutic agent in a therapeutically effective amount, a carrier component, titanium dioxide, and clay. A process for the preparation of a novel elastomeric composition of matter containing a therapeutic agent includes the steps of preparaing a masterbatch containing a therapeutic agent, adding the masterbatch to a rubber latex and thereafter forming and curing a desired product therefrom. The composition is useful in the manufacture of rubber goods such as surgical and medical products which can be single or multilayered.
Abstract: A novel elastomeric composition of matter comprises a rubber latex and a masterbatch comprising a therapeutic agent in a therapeutically effective amount, a carrier component, titanium dioxide, and clay. A process for the preparation of a novel elastomeric composition of matter containing a therapeutic agent includes the steps of preparing a masterbatch containing a therapeutic agent, adding the masterbatch to a rubber latex and thereafter forming and curing a desired product therefrom. The composition is useful in the manufacture of rubber goods such as surgical and medical products which can be single or multilayered.
Abstract: A synthetic vaccine is contemplated comprising a peptide residue coupled to one or more alkyl or alkenyl groups of at least 12 carbon atoms or other lipophilic substance wherein said peptide residue contains a sequence of 6 amino acids corresponding to the sequence of such amino acids in a protein antigen or allergen where the greatest local average hydrophilicity of the antigen or allergen is found.
Abstract: Cyclic disulfide and linear dynorphin Dyn A.sub.1-11 and dynorphin Dyn A.sub.1-13 analogs which are highly specific for .kappa. opioid receptors. These analogs are useful in pharmaceutical compositions and for the analysis of opioid receptor/ligand interactions.
Type:
Grant
Filed:
July 6, 1989
Date of Patent:
May 21, 1991
Assignee:
Arizona Technology Development Corporation
Abstract: A controlled release insect pest repellent comprising p-menthane-3,8-diol blended with an ethylene/vinyl acetate copolymer is disclosed. This controlled release insect pest repellent can show continuous controlled release of the repellent component, i.e., p-menthane-3,8-diol, for a prolonged period of time so as to effectively exterminate insect pests.
Abstract: A method is provided for inhibiting loss of cognitive function, including memory, which may or may not be associated with Alzhemier's disease, in a mammalian species by administering an ACE inhibitor, which is a phosphonate substituted amino or imino acid or salt, such as SQ 29,852 over a prolonged period of treatment.
Abstract: A stabilized somatotropin peptide aldehyde complex which provides prolonged release of the somatotropin and enhanced feed efficiency. The complex is prepared by dissolving the somatotropin and peptide aldehyde in water, isolating the complex from the aqueous solution, and crystalizing the product from alcohol. Specifically, the complex comprises porcine somatotropin and leupeptin and is particularly useful for enhancing feed efficiency in swine.
Abstract: Muscle quality of pigs normally susceptible to porcine stress syndrome is improved by administering to the pigs in conjunction with their daily feed ration, a small amount of porcine somatotropin.
Type:
Grant
Filed:
August 2, 1989
Date of Patent:
May 14, 1991
Assignee:
Iowa State University Research Foundation, Inc.
Abstract: An anti-infective medical article has chlorhexidine bulk distributed throughout a polyurethane base layer and may have a coating layer on the base layer. The coating layer may be chlorhexidine permeated into the surface or it may be an antibiotic, antithrombogenic agent or a polymeric surface layer laminated onto the base layer. The invention includes a method for preparing the article wherein a homogeneous melt of polymer and chlorhexidine is prepared by twin screw compounding and the melt is extruded to give a medical article having bulk distributed chlorhexidine.
Abstract: Loaded pollen grains are disclosed which are suitable for use as delivery systems for introducing biologically active substances into or on plants and animals. Such pollen grains are suitable to deliver both small and large (macromolecules) molecules. Preferred pollen grains are those that have been defatted and then pre-treated to be free of antigenic materials and that have special surface features that facilitate their attachment to tissue surfaces, particularly to mucous membranes. The most preferred pollen grains are those that have spiny or irregular or fragmented surfaces. Also disclosed are a method of pre-treating the pollen grains to remove antigenic materials; a method of loading the pollen grains with the biologically active material; and a method of incorporating such pre-treated, loaded pollen grains into formulations or dosage forms suitable for introduction into or on a plant or animal body.
Abstract: Pharmaceutical compositions comprising a combination of a polymeric biguanide and a spermicidal surfactant, useful for contraceptive purposes, for their spermicidal or sperm-immobilizing effect, and contraceptive methods and devices using them.The polymeric biguanide is preferably a compound as described in U.K. Patent Specification No. 702,268 or a bisbiguanide as described in U.K. Patent Specification No. 705,838 or 1,095,902, but especially chlorhexidine. The spermicidal surfactant may be derived from ethylene oxide, preferably a condensate of nonylphenol and ethylene oxide, and especially with 9 to 11 molecular proportions thereof.To avoid short-lived activity, the compositions are preferably made substantially free from anions (notably halide ions and especially chloride ions) which cause deactivation, apparently by reducing the solubility of the active ingredients.
Abstract: The invention relates to peptides of the formulaR.sup.N --L--N--B.sup.2 --R.sup.C (I)in which R.sup.N denotes an acyl radical, L denotes a radical of a lipophilic, neutral .alpha.-amino acid, N denotes a radical of an neutral .alpha.-amino acid, B.sup.2 denotes the radical of a basic .alpha.-amino acid, and R.sup.C denotes an amido radical; a process for their preparation, agents containing these peptides, and their use.
Type:
Grant
Filed:
January 8, 1990
Date of Patent:
April 30, 1991
Assignee:
Hoechst Aktiengesellschaft
Inventors:
Wolfgang Konig, Gerhard Breipohl, Rolf Geiger, Jochen Knolle, Max Hropot
Abstract: Novel fluorogenic substrates for retroviral protease, e.g. HIV protease, having the chemical structure X--Thr--Ile--Nle--Phe(Y)--Gln--Arg--NH.sub.2 wherein X is a fluorogenic group and Y is an acceptor for the fluorogenic group, and their use in a fluorometric method for the determination of retroviral protease is disclosed.
Abstract: Renin-inhibiting aminomethyl peptides of the formula ##STR1## in which A is H, an alkyl radical, a sulphonyl radical or an amino-protecting group,B, D, E and F each independently is a direct bond or an amino-organo-carbonyl group,R.sup.1 is an optionally substituted alkyl or aryl radical,R.sup.2 is H, alkyl or acyl,R.sup.3 is H, alkyl, aryl or acyl, andR.sup.4 is alkyl, alkoxy, aryl or amino,and physiologically acceptable salts thereof.
Type:
Grant
Filed:
August 17, 1989
Date of Patent:
April 23, 1991
Assignee:
Bayer Aktiengesellschaft
Inventors:
Rolf Henning, Gunter Benz, Johannes-Peter Stasch, Andreas Knorr, Wolfgang Bender
Abstract: There is disclosed a calcitonin derivative and its salt, comprising an amino acid residue at the 1-position of calcitonin which is a cyclic amino acid residue represented by the formula: ##STR1## wherein X represents a sulfur atom or a methylene group; and n represents an integer of 0 or 1. and an amino acid residue at the 7-position which is a cysteine residue which may be substituted with an appropriate protective group.
Abstract: A process for preparing a stable liquid enzyme concentrate containing the alpha-amylase from Bacillus stearothermophilus. A commercial alpha-amylase enzyme preparation is treated with granular starch to absorb the enzyme, and the starch containing the enzyme is separated and then heated in a buffer solution containing calcium ion. The resulting solution, separated from insoluble solid, is then concentrated to give the final product.
Abstract: Somatotropin is administered to food producing animals in the finishing stage of growth to increase fertility by increasing embryonic survival and litter size during the reproductive stage of growth.
Abstract: The invention relates to novel peptides and their acid addition salts, suppressing the function of the immune system, pharmaceutical compositions containing these peptides as well as to a process for preparing these peptides and compositions. The peptides are represented by formulae (1) to (16): ##STR1## The novel peptides are useful for the therapy of diseases where a decrease in the activity of the immune system is desirable.
Type:
Grant
Filed:
June 13, 1989
Date of Patent:
April 16, 1991
Assignee:
Richter Gedeon Vegyeszeti Gyar R. T.
Inventors:
Istvan Schon, Olga Nyeki, Lajos Kisfaludy, deceased, Laszlo Denes, Gyorgy Hajos, Laszlo Szporny